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Abstract
Background and purpose: Early atherosclerotic changes in ca-
rotid arteries can be detected using ultrasound examination.
The aim of this study was to assess correlations between inti-
ma-media thickness (IMT) and gender, age and clinical fea-
tures of diabetes mellitus (DM). 
Material and methods: The study group consisted of 73 pa -
tients with type 2 DM (mean age: 63.6 ± 7.5 years), and 
74 controls without DM (mean age 62.2 ± 7.5 years).
Analysed clinical features of diabetes included disease dura-
tion, anti-diabetic treatment, glycaemic control (HbA1c level),
presence of metabolic syndrome, and complications of macro-
and microangiopathy. IMT was measured using ultrasono -
graphy in the carotid arteries (common – CCA, bifurcation,
internal – ICA) bilaterally.
Results: Mean and maximum IMT in the CCA was greater
in diabetic patients than in controls. Age and male sex, but not
vascular risk factors, were independent predictors of increased
IMT in all segments. Macroangiopathy correlated with IMT
within both CCA in univariate analysis. After adjusting for
age and gender, this relationship remained significant in the
right CCA in middle-aged patients (59-67 years; p = 0.01 for
mean IMT, p= 0.02 for maximum IMT). In patients with-
out metabolic syndrome, IMT in the right CCA bifurcation
correlated with HbA1c level (p= 0.05). Patients treated simul-
taneously with insulin and oral antidiabetic drugs had smaller
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St reszc zen ie
Wstêp i cel pracy: Ultrasonografia têtnic szyjnych umo¿liwia
wykrycie wczesnych zmian mia¿d¿ycowych towarzysz¹cych
powik³aniom cukrzycy. Celem pracy by³o okreœlenie zale¿noœci
gruboœci kompleksu intima-media (KIM) od p³ci, wieku oraz
cech klinicznych cukrzycy.
Materia³ i metody: Zbadano 73 chorych na cukrzycê typu 2
(œrednia wieku 63,6 ± 7,5 roku) oraz 74 osoby bez cukrzy-
cy (œrednia wieku: 62,2 ± 7,5 roku). Do cech klinicznych
cukrzycy zaliczono: czas trwania choroby, leczenie przeciw-
cukrzycowe, kontrolê glikemii (stê¿enie HbA1c), obecnoœæ
zespo³u metabolicznego oraz powik³añ makro- i mikroan-
giopatycznych. Gruboœæ KIM oceniono ultrasonograficznie
obustronnie w trzech segmentach œciany dalszej têtnic szyj-
nych [wspólnej (CCA), bifurkacji oraz wewnêtrznej (ICA)].
Wyniki: U chorych na cukrzycê œrednia i maksymalna gru-
boœæ KIM w CCA by³a wiêksza ni¿ w grupie kontrolnej. Wiek
i p³eæ mêska stanowi³y niezale¿ne czynniki rokownicze pogru-
bienia KIM przy jednoczesnym braku wp³ywu naczyniowych
czynników ryzyka. W analizie jednoczynnikowej wykazano
korelacjê powik³añ makroangiopatii z gruboœci¹ KIM w ob -
rêbie obu CCA. Po uwzglêdnieniu wieku i p³ci zale¿noœæ ta
pozosta³a istotna w prawej CCA u chorych w wieku 59–67 lat
(p= 0,01 dla œredniej gruboœci KIM i p= 0,02 dla maksy-
malnej gruboœci KIM). U chorych nieobci¹¿onych zespo³em
metabolicznym stwierdzono korelacjê gruboœci KIM w ob -
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Introduction
Atherosclerosis develops progressively in several stages
and depends on exogenous and endogenous factors. 
The contribution of genetic abnormalities is unequivo-
cal and includes mutations leading to the polymorphisms
of genes involved in the basic atherothrombotic process-
es [1,2]. Among numerous exogenous factors, the influ-
ence of pathological glycation products and the oxida-
tive stress induced by the chronic hyperglycaemia,
in sulin resistance and hyperinsulinaemia is highlighted
[3-5]. Decreased production of nitric oxide (NO), as
well as increased concentrations of adhesive molecules
and free radicals, increases the endothelial damage, while
the insulin resistance antagonizes the positive effects of
insulin and accelerates progression of atheromatous
lesions [6,7]. Increased intima-media thickness (IMT),
as visualized with ultrasonography, has important prog-
nostic value for the development of cardiovascular dis-
eases and the development of atherosclerotic lesions in
carotid and peripheral arteries [8-15].
A strong correlation was found between IMT thick-
ness and the following variables: age, male sex, arterial
hypertension, hyperlipidaemia, smoking, obesity, leuko-
cytosis, concentrations of C-reactive protein, fibrinogen
and homocysteine, Chlamydia pneumoniae infection, dia-
betes mellitus (DM) and insulin resistance [16].
Diabetes mellitus plays a crucial role as an indepen-
dent risk factor for stroke in 37-42% of cases, especial-
ly among patients younger than 65 [17]. Microangio-
pathic complications, even in their preclinical stage
(microalbuminuria due to nephropathy), are associated
with acceleration of the atherosclerotic process and with
an increased risk of cardiovascular disorders [18,19].
Atherosclerotic lesions, when assessed ultrasono-
graphically, show faster increase of their area and vol-
ume than the more gradual and slow increase of IMT
[20], but the high incidence of complications as well as
important contribution of vascular and metabolic fac-
tors suggest the need for assessment of early lesions of
vessel walls in patients with type 2 DM and for the
determination of their clinical significance.
The aim of this study was to determine the relation-
ship between IMT thickness assessed in duplex ultra-
sound examinations and sex, age, or predefined clinical
features of DM.
Material and methods
The study included patients diagnosed with type 2
DM, aged between 50 and 70, who had no more than
three risk factors for cardiovascular disorders that have
a major impact on IMT in carotid arteries. Those risk
factors included arterial hypertension, smoking and dys-
lipidaemia. The study group involved 73 patients with
type 2 DM (mean age: 63.6 years; standard deviation
[SD]: 7.5). The control group consisted of 74 subjects
without DM (mean age: 62.2 years; SD: 7.5).
The protocol of the study was approved by the Bio -
ethical Committee at the Silesian Medical University of
Katowice. Each subject provided informed consent to
participate in this study.
According to the history and medical records, the fol-
lowing clinical features of DM were defined: (1) dis-
ease duration (measured in years since the diagnosis was
made); (2) method of anti-diabetic treatment (insulin,
oral hypoglycaemics, or combination of insulin and oral
medications); (3) control of glycaemia (HbA1c level [%]);
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IMT in the right ICA than those treated with insulin only
(0.471 ± 0.105 vs. 0.678 ± 0.209 mm; p= 0.04).
Conclusions: In diabetic patients, ultrasound IMT measu -
rement can be used to assess the cardiovascular risk and to
determine indications for intensified anti-diabetic treatment.
IMT is a sensitive marker of early carotid atherosclerosis,
particularly on the right side.
Key words: intima-media thickness, ultrasonography, diabetes
mellitus, microangiopathy, macroangiopathy, HbA1c.
rêbie bifurkacji prawej CCA ze stê¿eniem HbA1c (p= 0,05).
U chorych leczonych jednoczeœnie insulin¹ i lekami doustny-
mi stwierdzono mniejsz¹ œredni¹ gruboœæ KIM w prawej ICA
w porównaniu z osobami przyjmuj¹cymi wy³¹cznie insulinê
(0,471 ± 0,105 vs 0,678 ± 0,209 mm; p= 0,04).
Wnioski: Gruboœæ KIM u chorych na cukrzycê mo¿e s³u¿yæ
do oceny ryzyka chorób uk³adu kr¹¿enia oraz ustalenia wska-
zañ do intensyfikacji leczenia przeciwcukrzycowego. Jest
czu³ym wskaŸnikiem wczesnych zmian mia¿d¿ycowych,
a wiêksz¹ wartoœæ kliniczn¹ maj¹ pomiary przeprowadzane
w obszarze bifurkacji i têtnicy szyjnej wewnêtrznej po stro-
nie prawej.
S³owa kluczowe: kompleks intima-media, ultrasonografia,
cukrzyca, makroangiopatia, mikroangiopatia, HbA1c.
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(4) prevalence of metabolic syndrome, diagnosed ac -
cording to the International Diabetes Federation crite-
ria; (5) prevalence of macroangiopathic complications
(ischaemic heart disease, including myocardial infarc-
tion, peripheral artery disease, stroke or transient is chae -
mic attack [TIA]), analysed further in total; (6) pre va-
lence of microangiopathic complications (retinopathy,
nephropathy, neuropathy, diabetic foot), analysed fur-
ther in total.
The prevalence of arterial hypertension, smoking,
obesity, and dyslipidaemia was also noted.
Clinical examination involved the frequency and re -
gularity of the heart rhythm, measurement of the sys-
tolic and diastolic blood pressure, body weight, and body
mass index (BMI), as well as the signs of damage to 
the central and/or peripheral nervous system, including
features of diabetic neuropathy.
Intima-media thickness was measured using high re -
solution duplex sonography (Esaote MyLab60 appara-
tus). Measurements were performed in patients lying
down and with the head turned opposite to the side of 
the examined artery. A linear ultrasound probe emitting
ultrasound with the frequency changing between 5.6 and
8.0 MHz was used and the lateral approach was utilized.
IMT was measured manually in 2D images and B-mode
presentation according to the Mannheim Intima-Media
Thickness Consensus [9] within the three segments of
the far wall of the carotid without atherosclerotic lesions
(Fig. 1): (1) at the level of the common carotid artery
(CCA), within a 10-mm distance (or 20 mm if an athe -
ro sclerotic lesion was present) from the bifurcation, at five
points separated from each other by 2-4 mm; (2) at the
level of the bifurcation, at three points chosen in regard
of the length of the bifurcation segment and the presence
of atherosclerotic lesions; (3) at the level of the internal
carotid artery (ICA), at three points within a 10-mm dis-
tance from the bifurcation carina, or beyond that distance,
if the atherosclerotic lesions were found in that location.
The differentiation between thickened intima-media com-
plex and atherosclerotic plaque was made using the de fi-
nition provided by the Mannheim Carotid Intima-Media
Consensus, which describes the latter as a focal structure
thicker than 1.5 mm, or a small structure encroaching
into the arterial lumen of at least 0.5 mm, or thicker by
> 50% than the surrounding IMT value.
Data from IMT measurements within the CCA bi -
furcation and the initial ICA segment were provided se -
pa rately. In each case, maximal and mean values of mea-
surements within the CCA were reported, and the mean
values of measurements within the bifurcation and ICA.
Statistical analysis
Statistical analysis was performed using the STA-
TISTICA v. 5.5 statistical package as well as Excel 2007.
A p-value of 0.05 or less was considered statistically sig-
nificant. Distribution of most quantitative variables de -
viated significantly from normal (as assessed by Shapiro-
Wilk test); thus, the univariate analyses were performed
with non-parametric tests. Comparisons between two
groups were made with Mann-Whitney U-test, and com-
parisons among three groups were made with Kruskal-
Wallis test. The univariate analysis of dichotomous vari-
ables in 2 × 2 contingency tables was performed with
Fisher exact test, and in the case of 3 × 2 contingency
tables, a χ2 test with Yates correction was used.
The analysis also included multiple regression.
ANCOVA was used to test the effect of independent
variables, if they were not presented in an ordinal scale.
A logistic regression analysis was used if the dependent
variable could be reported as a dichotomous variable.
Age and disease duration were considered as the conti -
nuous covariables in ANCOVA. Tables include the p-va -
lue at the moment of removal from the model for the re -
moved variables and the p-value for those variables that
were left in the model. In the case of independent vari-
ables measured on an ordinal scale, a p-value is accom-
panied by a ‘+’ or ‘–’ sign to show the direction of rela-
tionship between dependent and independent variables
(a ‘+’ sign means that an increased value of the inde-
pendent variable increases the value of the dependent
variable and vice versa). A ‘+M’ sign was added in cas-
es where male sex had an important effect on the depen-
dent variable.
CCA – common carotid artery; ICA – internal carotid artery
Fig. 1. Carotid artery segments according to Mannheim Intima-Media Thickness
Consensus 
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Results
Patients with type 2 DM were similar to controls re -
garding sex and age. Table 1 provides demographic cha-
racteristics, as well as clinical and biochemical features 
of patients and controls. The distribution of the analysed
cardiovascular risk factors among patients with type 2 DM
and controls is also provided in Table 1. Obesity, meta-
bolic syndrome, arterial hypertension and cardiovascular
risk factors (macroangiopathic complications) were all
more prevalent in patients with type 2 DM (Table 1).
Vast atherosclerotic lesions in examined segments of
vessels, and, to a minor extent, also pathological obesi-
ty, precluded IMT assessment in 6.5% of patients with
type 2 DM (29/444 segments), and in 2.7% of controls
(12/438 segments). The completeness of measurements
was highest in CCA (100% in both groups) and the low-
est in ICA (90% in patients and 96% in controls).
Mean and maximal IMT was significantly greater
in DM patients than in controls (Table 2).
Age and male sex, but not vascular risk factors, were
independent predictors of increased IMT in all seg-
ments among patients with DM.
Univariate analysis showed a significant correlation
between the presence of macroangiopathic compli cations
and the IMT within the left and right CCA. Multiple
regression analysis showed a strong effect of (1) age on
the IMT in both CCAs and in the right-sided bifurca-
tion, (2) male sex on the IMT in all left-sided segments,
and (3) duration of the disease on the IMT within the
left ICA. All those factors attenuated the correlation
shown in univariate analysis with the exception of pa -
tients aged 59-67, in whom the correlation of IMT with
the macroangiopathic complications remained signifi-
cant for the right CCA (Tables 3 and 4). Among
patients aged between 59 and 67, a significant influence
Wojciech Bartman, Krystyna Pierzcha³a
Patients with diabetes Controls P-value
(n = 73) (n = 74)
Age [years], mean ± SD 63.6 ± 7.5 62.2 ± 7.5 0.30
Women 37 (50.68%) 45 (60.81%) 0.22
Arterial hypertension 60 (82%) 49 (66%) 0.03
Dyslipidaemia 56 (77%) 49 (65%) 0.21
Smoking 10 (14%) 13 (17%) 0.67
Subjects treated with:
oral hypoglycaemics 36 (49.3%) – –
insulin 24 (32.9%) – –
insulin and oral hypoglycaemics 13 (17.8%) – –
statins 44 (60.3%) 28 (37.8%) 0.01
any hypotensive drug 52 (71.2%) 34 (43.2%) 0.003
Microangiopathy 32 (43.8%) – –
Macroangiopathy 42 (57.5%) 30 (40.54%) 0.04
Blood fasting glucose [mmol/L]; mean ± SD 8.05 ± 2.44 5.64 ± 1.11 < 0.000001
HbA1c level [%] 7.43 ± 1.29 – –
Obesity 37 (51%) 17 (23%) 0.004
Body mass index; mean ± SD 30.29 ± 4.95 27.22 ± 3.99 0.08
Metabolic syndrome 55 (75%) 29 (39.2%) 0.00002
Diabetes duration [years]; mean ± SD 11.7 ± 8.1 – –
Table 1. Age, gender, clinical and biochemical characteristics in diabetic patients and controls
SD – standard deviation
Data are presented as n (%), if not otherwise stated.
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of macroangiopathic complications was noted for mean
IMT in the right CCA [F(1,21) = 7.51, p= 0.01] and
for maximum IMT in the right CCA [F(1,21) = 7.01,
p = 0.02]. Presence of complications was associated
with higher values of those measurements. No correla-
tion was found between IMT and the presence of
microangiopathic complications among DM patients.
Intima-media thickness did not correlate with HbA1c
concentration in the whole study group. When patients
with metabolic syndrome were excluded, such a corre-
lation was found for the mean IMT within the bifurca-
tion of the right CCA (Spearman rank correlation coef-
ficient, r= 0.61, p= 0.05).
A significant association was found between the me -
thod of anti-diabetic treatment and the mean and maxi -
mal IMT within the right CCA and the mean IMT
within the right ICA – the lowest IMT in those seg-
ments was noted among patients treated with oral hypo-
glycaemics when compared to those treated with insulin
alone or to the patients treated with both insulin and oral
Intima-media thickness [mm] P-value
Diabetic patients Control group
n = 73 n = 74
Max. right CCA 0.852 ± 0.2 0.763 ± 0.185 0.004
Mean right CCA 0.731 ± 0.167 0.667 ± 0.155 0.01
Mean right bifurcation 0.816 ± 0.263 0.788 ± 0.227 0.3
Mean right ICA 0.593 ± 0.206 0.557 ± 0.189 0.17
Max. left CCA 0.916 ± 0.236 0.786 ± 0.162 0.0004
Mean left CCA 0.775 ± 0.19 0.681 ± 0.133 0.0009
Mean left bifurcation 0.866 ± 0.23 0.8 ± 0.247 0.09
Mean left ICA 0.616 ± 0.218 0.552 ± 0.167 0.1
Table 2. Mean values of intima-media thickness in diabetic patients and controls
CCA – common carotid artery; ICA – internal carotid artery
Patients with Patients without P-value Patients with Patients without P-value
macroangiopathy macroangiopathy microangiopathy microangiopathy
(n = 43) (n = 30) (n = 32) (n = 41)
Age [years]* 66 ± 6.8 60 ± 7.5 0.004 65 ± 7.6 62 ± 7.3 0.12
Men [n (%)] 22 (51) 14 (47) 0.18 12 (37.5) 24 (58) 0.10
Intima-media thickness [mm]*
Mean left CCA 0.807 ± 0.203 0.724 ± 0.164 0.03 0.806 ± 0.208 0.751 ± 0.173 0.20
Max. left CCA 0.962 ± 0.249 0.85 ± 0.2 0.03 0.95 ± 0.24 0.89 ± 0.23 0.22
Mean left 0.907 ± 0.240 0.81 ± 0.199 0.09 0.851 ± 0.208 0.88 ± 0.247 0.82
bifurcation
Mean left ICA 0.625 ± 0.222 0.6 ± 0.215 0.52 0.653 ± 0.211 0.59 ± 0.22 0.18
Mean right CCA 0.757 ± 0.138 0.687 ± 0.197 0.05 0.726 ± 0.153 0.734 ± 0.18 0.86
Max. right CCA 0.878 ± 0.161 0.81 ± 0.242 0.12 0.85 ± 0.197 0.85 ± 0.20 0.95
Mean right 0.865 ± 0.266 0.815 ± 0.256 0.34 0.845 ± 0.29 0.847 ± 0.243 0.57
bifurcation 
Mean right ICA 0.593 ± 0.213 0.585 ± 0.2 0.90 0.65 ± 0.24 0.55 ± 0.17 0.15
Table 3. Comparison of age, gender, and intima-media thickness in relation to the macro- and microangiopathic complications in diabetic patients (univariate analysis)
*mean ± standard deviation
CCA – common carotid artery; ICA – internal carotid artery
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hypoglycaemics (mean IMT in right CCA = 0.692 ±
0.157 vs. 0.790 ± 0.164 vs. 0.727 ± 0.418 mm, respec-
tively, p= 0.03; maximum IMT in right CCA = 0.804
± 0.104 vs. 0.920 ± 0.210 vs. 0.862 ± 0.245 mm,
respectively, p= 0.03; mean IMT in right ICA = 0.569
± 0.206 vs. 0.678 ± 0.209 vs. 0.471 ± 0.105 mm,
respectively, p= 0.01). Duration of the disease correlat-
ed positively with mean and maximal values of IMT in
the right CCA, as well as with mean IMT values in the
right ICA. It is worth noting that patients receiving oral
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IMT Age Gender Diabetes duration Macroangiopathy Microangiopathy
Mean left CCA 0.002 (+) 0.008 (+M) 0.39 0.41 0.13
  β= 0.34 ± 0.11 β= 0.29 ± 0.11
Max. left CCA 0.02 (+) 0.004 (+M) 0.21 0.29 0.11
 β = 0.26 ± 0.11 β = 0.33 ± 0.11
Mean left bifurcation 0.34 0.04 (+M) 0.47 0.26 0.86
 β = 0.25 ± 0.12
Mean left ICA 0.17 0.03 (+M) 0.72 0.71 0.23
 β = 0.27 ± 0.12
Mean right CCA 0.003 (+) 0.72 0.07 (+) 0.36 0.13
 β = 0.37 ± 0.11 β = 0.20 ± 0.11
Max. right CCA 0.004 (+) 0.63 0.06 (+) 0.59 0.18
 β = 0.35 ± 0.11 β = 0.22 ± 0.11
Mean right bifurcation 0.03 (+) 0.28 0.46 0.99 0.63
 β = 0.27 ± 0.12
Mean right ICA 0.08 0.60 0.005 (+) 0.57 0.33
 β = 0.35 ± 0.12
Table 4. Intima-media thickness (IMT) in relation to clinical characteristics of diabetes characteristics – multiple regression analysis (p-values are reported; for signi-
ficant relationships, beta coefficient values with respective standard errors were also provided)
CCA – common carotid artery; ICA – internal carotid artery
‘+’ sign means that an increased value of the independent variable increases the value of the dependent variable. 
A ‘+M’ sign suggests that male sex has an important effect on the dependent variable.
Diabetic patients Diabetic patients treated
treated with insulin only both with insulin
(n = 24) and oral hypoglycaemics 
(n = 13)
Maximal daily dose of insulin [IU] 53.04 ± 21.8 49.8 ± 22.2
Obesity, n (%) 11 (45.8%) 12 (92.3%)
Metabolic syndrome, n (%) 20 (83.33%) 11 (84.6%)
Systolic blood pressure [mm Hg] 142.9 ± 19.67 144.6 ± 16.13
Diastolic blood pressure [mm Hg] 80.42 ± 11.97 78.07 ± 10.9
HbA1c [%] 7.89 ± 1.1 7.41 ± 1.38
LDL [mmol/L] 3.23 ± 1.2 2.68 ± 0.8
HDL [mmol/L] 1.25 ± 0.29 1.23 ± 0.23
Triglycerides [mmol/L] 2.00 ± 1.07 1.97 ± 0.52
Statins, n (%) 13 (54.2%) 8 (61.5%)
Table 5. Characteristics of diabetic patients treated with insulin alone or taking insulin and oral hypoglycaemics together
SD – standard deviation
Data are presented as mean ± standard deviation, if not otherwise stated.
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hypoglycaemics had shorter duration of the disease (8.5
± 6.4 years) than those treated with insulin alone (14.4
± 9.0 years) or patients receiving both insulin and oral
hypoglycaemics (15.6 ± 7.5 years, p= 0.002). There-
fore, a separate analysis was performed among patients
treated either with insulin or both with insulin and oral
hypoglycaemics, in whom the duration of the disease was
similar. Again, in patients receiving combined treatment,
lower mean IMT was noted in the right ICA. Patients
receiving combined treatment were more often obese,
had higher BMI, lower HbA1c concentration and low-
er LDL cholesterol concentration, and received statins
more commonly (Table 5).
Discussion
Diabetes mellitus is an independent risk factor for
atherosclerosis and resulting cardiovascular complica-
tions. Patients with impaired glucose tolerance and, to
a greater extent, DM patients have increased IMT
[21]. Increased IMT in carotid arteries can be noted
even in patients diagnosed de novo with DM, which
suggests that this abnormality occurs before the clinical
manifestation of the disease [22]. Major determinants
of increased IMT among diabetic patients include 
obesity, dyslipidaemia and hyperinsulinaemia, which
constitute the cardinal features of insulin resistance syn-
drome. Thickening of the intima-media complex is espe-
cially clear in patients who have experienced macroan-
giopathic complications [23]. 
Intima-media thickness within the CCA is greater in
diabetic patients than in controls, especially on the left,
which results from the anatomical and hemodynamic dif-
ferences in the biomechanical forces affecting the vessel
wall and generated by the blood flow on both sides [24].
Age and male sex were strong determinants of IMT
in diabetic patients, similarly to the relationship noted
in healthy subjects. No relationship was found between
IMT and analysed cardiovascular risk factors (although
the p-value was close to significant in the case of IMT
within the bifurcation of the right CCA), probably be -
cause of the strong impact of age and due to the greater
impact of the metabolic abnormalities typical for DM,
as noted also by others [25,26].
We observed an association between IMT and the
prevalence of macroangiopathic complications of DM;
this association remained significant in patients aged 
58-67 when the impact of age and male sex was con-
trolled for.
A strong association between IMT and vascular risk
factors, ischaemic heart disease and symptomatic athe -
rosclerosis in other locations, including stroke, has been
confirmed in numerous studies [27-29].
Among patients with stroke of atherothrombotic ori-
gin, the risk of stroke increases proportionally to the
IMT, and greater IMT within the CCA is associated
with increased risk of stroke recurrence [30]. Our find-
ings confirm the significance of IMT assessed with
ultrasonography as a predictor of cardiovascular disease
risk in patients with type 2 DM. It is interesting that
a correlation was found in some segments of the stud-
ied arteries between IMT and glycaemic control as
defined by the HbA1c concentration. It was shown in
patients with DM who had no metabolic syndrome, and
in whom the disturbances related to the disease itself
prevail over the effect of cardiovascular risk factors. 
Both the ARIC and INVADE studies showed that
the HbA1c concentration is an independent factor relat-
ed to the IMT in patients with DM and with cardio-
vascular disease risk [31]. No cut-off point for the
development of complications was suggested, however.
Nevertheless, it was stated that the reduction of HbA1c
concentration by 1% decreases the risk of incident
myocardial infarction by 14% and stroke by 11%. There
was no difference, however, in terms of the incidence of
cardiovascular complications between those treated
aggressively (HbA1c ≤ 7.0%) and patients receiving
dietary treatment only (HbA1c = 7.9%) during the 
15-year follow-up [32,33].
Better glycaemic control translates into the dynam-
ics of the development of early atherosclerotic lesions and
into the decreased risk of cardiovascular diseases, as sug-
gested by the meta-analysis of ACCORD, ADVANCE,
UKPDS, and VADT studies [34]. Even in patients with
good glycaemic control (HbA1c = 5.8-6.4%) further
improvement in glycaemic control prevents thickening
of the intima-media complex in carotid arteries, and ultra-
sonography is a valuable method enabling monitoring of
the progression of those lesions [35]. IMT depends on
the duration of the DM, while the increase of HbA1c by
1% per year of the disease increases the risk of intima-
media thickening by 30% [36].
The gradual increase of the atherosclerotic lesions
in carotid arteries, noted in healthy subjects, patients
with newly diagnosed DM and in those with previously
diagnosed DM, points to the important effect of disease
duration on atherosclerosis development within the ca -
rotid arteries and to the presence of the lesions even in
a preclinical stage [37].
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We have analysed the possible impact of anti-diabe -
tic treatment and found significantly smaller IMT in
patients receiving oral hypoglycaemics. They had the
shortest disease duration, which persuaded us to perform
a separate analysis limited to patients treated with insulin
only or with insulin plus oral hypoglycaemics who had
similar duration of the disease. It showed the advantage
of the combined treatment for the IMT in the right ICA.
Few studies have been published so far regarding the
IMT within the carotids in patients treated with insulin
only and in those treated with oral agents; their results
are divergent. Large prospective studies conclude that
more intense anti-diabetic treatment may result in sig-
nificantly lower incidence of serious cardiovascular 
complications [34]. This applies to patients treated 
with oral hypoglycaemics and to those receiving insulin.
The EDIC study, conducted in young (13-40 years)
patients without additional cardiovascular risk factors,
did not show significant differences in IMT within CCA
or ICA between those treated aggressively and in patients
treated conventionally. Intensive therapy with insulin
reduced the risk of any incident cardiovascular compli-
cation by 42%, reduced the risk of myocardial infarction
or stroke by 57% and significantly reduced the risk of
microangiopathic complications [38]. 
Comparison of type 2 DM patients treated with
insulin of mixed content (Mix 30) and those receiving
insulin injections more often (4 times daily) showed
a beneficial effect of more aggressive treatment on the
glycaemic control (HbA1c concentration) but not for
the IMT in carotid arteries [39]. Six-month observa-
tion suggested a benefit of intensive polytherapy (three
oral medications with divergent mechanisms of action)
in terms of the IMT in carotid arteries among patients
with newly (< 1 year) diagnosed DM (0.88 ± 0.26 mm
vs. 0.96 ± 0.22 mm) [40]. New and more persuasive
evidence may be provided by the Copenhagen Insulin
and Metformin Therapy Trial (CIMT), which began
in 2008 and whose final findings are expected in 2014.
The primary outcome is the progression of the IMT in
carotid arteries in patients with type 2 DM treated
simultaneously with insulin and metformin in compari -
son to those treated with insulin only [41].
In our study, patients receiving aggressive treatment
were more frequently treated also with statins with con-
sequent normalization of lipid profile; no association was
found between the IMT and the presence of dyslipi-
daemia. It is worth, however, taking into account the
vast and pleiotropic mechanism of action of statins,
which is independent of their lipid-lowering effect [42].
Our findings suggest that the intensification of anti-dia-
betic treatment has a positive impact on the early changes
occurring in the ICAs and, indirectly, on the risk of car-
diovascular diseases.
It is noteworthy that most of the correlations among
IMT and analysed clinical features of DM were relat-
ed to the specific segments and predominated on the
right side. IMT in young subjects does not differ bet -
ween sides [43], while in the following years it is greater
on the left. Among subjects aged over 65 and burdened
with cardiovascular diseases this difference diminishes
[44], suggesting the domination of the atherosclerotic
processes over the biomechanical forces remodelling 
the vessel walls. It may be supposed that the decreased
adaptation of the carotid artery walls to the haemody-
namic conditions is responsible for the excessive response
and the faster progression of abnormalities on the right
side. Greater IMT on the right side was reported in
patients with borderline hypertension or with isolated
systolic hypertension; IMT of the right CCA is also
a predictor of acute coronary events in patients with sta-
ble ischaemic heart disease [45]. The diverse distribu-
tion of lesions within the walls of carotid arteries has also
been reported by others. The results of the CARDIA
study suggested that DM, arterial hypertension and
smoking had a greater impact on IMT within the bifur-
cation, while the LDL concentration affected mostly
IMT within the ICA [46]. 
In the CAPS study, vascular risk factors, including
diabetes, correlated to a greater extent with the IMT pro-
gression in the ICA than in the CCA [47]. This sug-
 gests the divergent response of the intima-media com-
plex on each side for the effect of specific haemodynamic,
metabolic and biochemical factors, and the divergent pre-
dictive value of the measurements performed within the
carotid arteries on both sides.
Conclusions
1. The findings of this study confirm the high utility of
ultrasonographic assessment of IMT in patients with
type 2 DM as a sensitive marker of early atheroscle-
rotic changes in carotid arteries, showing the greater
clinical value of measurements performed within the
bifurcation and ICA on the right side.
2.  The association between IMT in carotid arteries and
the occurrence of macroangiopathic complications
and glycaemic control in diabetic patients in a specific
age and with vascular risk factors, as well as the asso-
cia tion between IMT and the method of anti-diabetic
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treatment, might be used for the assessment of risk
of cardiovascular diseases and for the determination
of indications for more aggressive treatment in order
to achieve optimal metabolic control.
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